Acción ADAP ADAPTIMMUNE THERAPEUTICS PLC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Adaptimmune Therapeutics plc

Acciones

ADAP

US00653A1079

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
1,075 USD +1,42 % Gráfico intradía de Adaptimmune Therapeutics plc +10,06 % +35,56 %
24/04 La renta variable europea cotizó en EE.UU. como recibos de depósito estadounidenses con tendencia a la baja en la negociación del miércoles MT
23/04 Las acciones europeas negociadas en EE.UU. como recibos de depósito estadounidenses saltan en la negociación del martes MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
Roche: Genentech met fin à la collaboration avec Adaptimmune Therapeutics
Roche-Tochter Genentech beendet Zusammenarbeit mit Adaptimmune Therapeutics
Adaptimmune Therapeutics Says Unit Gets Termination Notice for Strategic Collaboration With Genentech
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher
Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading
European Equities Traded in the US as American Depositary Receipts Ease Wednesday
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ADAP
  4. Noticias Adaptimmune Therapeutics plc
  5. Otros idiomas